Genprex reduces stockholder meeting quorum from majority to one-third

Genprex, Inc.

Board approved amendment on Oct 18, 2023, reducing quorum to 33⅓% of voting power.
Previous bylaw required a majority of outstanding shares entitled to vote.
Effective immediately upon board approval.
Amendment filed as Exhibit 3.1.

item 5.03 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Genprex, Inc.: Reduced stockholder meeting quorum from majority to one-third of voting power (effective 2023-10-18).

Change: bylaw amendment
Effective: 2023-10-18

Exact text from the filing

The Amendment reduces the quorum at all meetings of the Company’s stockholders for the transaction of business, except as otherwise required by law or by the Company’s Amended and Restated Certificate of Incorporation or Bylaws, to one-third (331⁄3%) of the voting power of the stock outstanding and entitled to vote at the meeting, present in person, present by remote communication, if applicable, or represented by proxy.

View on SEC.gov

Browse all governance changes →

Genprex, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-23-028769

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.